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Abstract
 
V
 
 
 
2 T lymphocytes recognize nonpeptidic antigens without presentation by MHC molecules
and mount both immediate effector functions and memory responses after microbial infection.
However, how V
 
 
 
2 T cells mediate different facets of a memory response remains unknown.
Here, we show that the expression of CD45RA and CD27 antigens defines four subsets of hu-
man V
 
 
 
2 T cells with distinctive compartmentalization routes. Naive CD45RA
 
 
 
CD27
 
 
 
 and
memory CD45RA
 
 
 
CD27
 
 
 
 cells express lymph node homing receptors, abound in lymph
nodes, and lack immediate effector functions. Conversely, memory CD45RA
 
 
 
CD27
 
 
 
 and
 
terminally differentiated CD45RA
 
 
 
CD27
 
 
 
 cells, which express receptors for homing to in-
flamed tissues, are poorly represented in the lymph nodes while abounding at sites of inflam-
mation, and display immediate effector functions. These observations and additional in vitro
experiments indicate a lineage differentiation pattern for human V
 
 
 
2 T cells that generates na-
ive cells circulating in lymph nodes, effector/memory cells patrolling the blood, and terminally
differentiated effector cells residing in inflamed tissues.
Key words:
 
   
 
cells • effector functions • chemokine receptors • functional subsets • 
phosphoantigens
 
Introduction
 
  
 
 T cells are a minor T cell population with a unique
pattern of antigen recognition. Several types of antigen
specificities have been reported for human and mice 
 
  
 
cells; they include allo-MHC molecules, peptide–MHC
complexes, stress-related proteins such as MICA/B and
heat shock protein 60, and nonpeptidic molecules (for re-
view see reference 1). The vast majority of circulating 
 
  
 
 T
cells in humans express a TCR heterodimer comprised of
V
 
 
 
9 and V
 
 
 
2 chains that directly recognize nonpeptide
ligands without presentation by MHC molecules (1). The
nonpeptide ligands, referred to as phosphoantigens, com-
prise natural phosphoesters derived from mycobacteria (2–
5), and to a lesser extent several ubiquitous metabolites
such as alkylamines from plant extracts (6), xylosyl- or ribo-
syl-1–phosphate, 2,3-diphosphoglycerate (7), and several
synthetic aminobisphosphonates (8). Common to all of
these small compounds (molecular mass below 500 D) is
the presence of either a pyrophosphate or a primary amine
located at the distal end of their organic C2-C5 skeleton.
With regard to peptide/MHC recognition by conven-
tional 
 
  
 
 TCR, phosphoantigen recognition by V
 
 
 
9V
 
 
 
2
TCR presents unusual features. First, V
 
 
 
9V
 
 
 
2 cells cir-
cumvent the need for APCs to interact with phosphoanti-
gens, as these ligands seem to bind directly to the reactive
TCR, enabling isolated 
 
  
 
 cells to respond to exogenous
soluble phosphoantigens (9, 10). Second and more strik-
ingly, phosphoantigen recognition by any V
 
 
 
9V
 
 
 
2 cells is
simultaneously cross-reactive (different molecules are rec-
ognized) and ligand-discriminating (structurally related mol-
ecules are not recognized; reference 11).
V
 
 
 
9V
 
 
 
2 cells are not the predominant 
 
  
 
 subset in pe-
ripheral blood at birth. Rather, their number increases
from birth and peaks at 
 
 
 
7 yr of life in the absence of a
parallel thymic wave, pointing to an environmental anti-
gen-driven peripheral expansion (12). Accordingly, cord
blood V
 
 
 
9V
 
 
 
2 T cells express the CD45RA naive pheno-
type, whereas the majority of adult V
 
 
 
9V
 
 
 
2 T cells express
the CD45RO memory phenotype (12).
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Human V
 
 
 
2 T Cell Subsets
 
V
 
 
 
9V
 
 
 
2 T cells have been shown to be capable of both
immediate effector functions (such as cytokine production
and cytotoxic activity; reference 1) as well as to mount a
memory response upon microbial reinfection (13–15), sug-
gestive of the existence of different functional subsets (16).
Recently, two subsets of V
 
 
 
2 T cells have been described
in humans, based on expression of CD27: CD27
 
 
 
 cells
proliferate but produce low IFN
 
 
 
, whereas CD27
 
 
 
 cells
show reciprocal properties (17). However, in contrast to
human CD4 and CD8 T cells, description of V
 
 
 
2 naive,
memory, and effector phenotypes is still rather fragmentary.
In this work, we have used simultaneous staining with
CD45RA and CD27 mAbs to separate functionally distinct
subpopulations of human V
 
 
 
2 T cells.
 
Materials and Methods
 
Subjects.
 
PBMCs were obtained from the heparinized blood
of 15 healthy volunteers upon informed consent. Mononuclear
cells were taken from inguinal lymph nodes of six organ donors
collected to perform HLA typing and cross-match analysis for
organ transplantation. We selected lymph node specimens from
donors who neither received drugs nor blood or plasma transfu-
sion, and who had no signs of infection. Additionally, mononu-
clear cells were collected from one ascitic and two cerebrospinal
fluids from three patients affected by tuberculous peritonitis and
meningitis, respectively. None of these three patients had evi-
dence of HIV infection, or was being treated with steroids or an-
titubercular drugs at the time of diagnosis and inflammatory flu-
ids sampling.
 
FACS
 
®
 
 Staining and Sorting.
 
PBMCs were isolated from hep-
arinized blood, lymph nodes, or inflammatory fluids, by Ficoll-
Hypaque (Amersham Biosciences). For subset identification,
PBMCs were incubated with the following antibodies in different
combinations: anti-V
 
 
 
2 FITC (IMMU389; Coulter), anti-CD27
PE (M-T271; BD Biosciences), anti-CD45RA PE-Cy5 (2H4;
Coulter), anti-CD45RO PE-Cy5 (UCHL-1; Coulter), anti-
CD62L allophycocyanin (Dreg56; BD Biosciences), anti-CD3
PE (UCHT-1; Sigma-Aldrich), anti-CD4 PE (Q420; Sigma-
Aldrich), anti-CD8 PE (UCHT-4; Sigma-Aldrich), and anti-V
 
 
 
9
unconjugated (B3; BD Biosciences).
Staining with purified antibodies to human chemokine recep-
tors CXCR3, CCR2, CCR6 (R&D Systems), CCR5 (BD Bio-
sciences), and CCR7 (provided by M. Lipp) was followed by al-
lophycocyanin-conjugated anti–mouse or anti–rat IgG antibodies
(BD Biosciences). Data were acquired on a FACSCalibur™ in-
strument (BD Biosciences) and analyzed using CELLQuest™
software (BD Immunocytometry Systems).
Cell sorting was performed on a FACSVantage™ (BD Bio-
sciences).
 
Proliferation, IFN
 
 
 
 Production, and BLT-esterase Release As-
says.
 
The medium used throughout was complete RPMI 1640
medium (GIBCO BRL) supplemented with 10% heat-inacti-
vated FCS (GIBCO BRL), 2 mM 
 
l
 
-glutamine, 20 nM Hepes,
and 100 U/ml penicillin/streptomycin. Sorted V
 
 
 
2 cell subsets
were cultured at 37
 
 
 
C in the presence of 5% CO
 
2
 
, at 10
 
6
 
/ml in
96-well flat-bottomed plates (0.2 ml/well), with different con-
centrations of isopentenyl pyrophosphate (IPP;
 
*
 
 Sigma-Aldrich).
 
Proliferation was measured 72 h later by adding 1 
 
 
 
Ci/well of
[
 
3
 
H]thymidine (Amersham Biosciences) during the last 6 h of cul-
ture. Cells were harvested, and [
 
3
 
H]thymidine incorporation was
measured with a liquid scintillation 
 
 
 
-counter. Results are ex-
pressed as mean counts per minute of triplicate wells 
 
 
 
 SD. IFN
 
 
 
levels in the 24-h culture supernatants were assessed by two-mAbs
sandwich ELISA assay following the manufacturer’s recommenda-
tions (R&D Systems). N
 
 
 
-CBZ-
 
l
 
-lysine-thiobenzyl (BLT)-
esterase levels in 24-h culture supernatants were determined by
the BLT-esterase assay. In brief, 20 
 
 
 
l of culture supernatant was
incubated with 35 
 
 
 
l 1 mM BLT (Sigma-Aldrich), 35 
 
 
 
l 1 mM
5–5
 
 
 
-dithio-bis-(2-nitrobenzoic acid; Sigma-Aldrich), and 10 
 
 
 
l
0.1% Triton X-100 (Sigma-Aldrich). After incubation for 30 min
at 37
 
 
 
C, the absorbance at 405 nm was measured.
 
Cell Cultures.
 
Sorted V
 
 
 
2 subsets were cultured for 12 d with
IPP, as described in the 
 
Proliferation, IFN
 
 
 
 Production, and BLT-
esterase Release Assays 
 
section, except 20 U/ml human recombi-
nant IL-2 was added at the third and the sixth day of culture. Af-
ter the culture period, cells were recovered and surface marker
expression assessed by FACS
 
®
 
. Additionally, the cells were re-
stimulated with IPP as described in the 
 
Proliferation, IFN
 
 
 
 Produc-
tion, and BLT-esterase Release Assays 
 
section: proliferation was
measured after 72 h by [
 
3
 
H]thymidine incorporation and IFN
 
 
 
levels in the 24-h culture supernatants assessed by two-mAbs
sandwich ELISA assay. The length of telomeres was determined
using a Teloquant kit (BD Biosciences).
 
Results and Discussion
 
Staining of PBMCs with antibodies to CD45RA and
CD27 identifies three subsets of V
 
 
 
2 T cells (Fig. 1 A): one
subset with a naive CD45RA
 
 
 
CD27
 
 
 
 phenotype and two
subsets with a memory CD45RA
 
 
 
CD27
 
 
 
 and CD45RA
 
 
 
CD27
 
 
 
 phenotype.
In a population of healthy adult donors (Fig. 1 D, 
 
n
 
 
 
 
 
15), the distribution of the V
 
 
 
2 subsets, as defined by
simultaneous CD45RA and CD27 staining was as fol-
lows: CD45RA
 
 
 
CD27
 
 
 
 cells, 21.4 
 
 
 
 5.7 (range 14–34);
CD45RA
 
 
 
CD27
 
 
 
 cells, 52.1 
 
 
 
 10.1 (range 36–66); and
CD45RA
 
 
 
CD27
 
 
 
 cells, 26.5 
 
 
 
 15.3 (range 0–50). In all
tested individuals, the V
 
 
 
2
 
 
 
 T cells were CD3
 
 
 
 and double
(CD4 and CD8) negative, even if in two patients 1.3% and
0.8% of the V
 
 2  cells stained positive for CD8. Fig. 1 (B
and C) shows typical two-color FACS® analysis for V 2/
CD3 and V 2/CD8 expression.
To further define the cell surface phenotype of these
subsets and to address if they had a different migratory ma-
chinery, V 2 T cell subsets were sorted yielding  98%
pure populations and analyzed with antibodies to different
chemokine receptors and adhesion molecules. Data are re-
ported in Table I. CD45RA CD27  cells showed charac-
teristics of naive cells because they were CD45RO  and
expressed the lymph node homing receptors CCR7 and
CD62L (18, 19), while lacking expression of receptors for
inflammatory chemokines such as CCR2, CCR5, CCR6,
and CXCR3 (20). CD45RA CD27  cells share chemo-
kine receptor expression with naive cells because they still
express high levels of CD62L and CCR7, but  25% of
these cells also express CCR5 and CXCR3. Despite ex-
pression of the secondary lymphoid organs homing chemo-
*Abbreviations used in this paper: BLT, N -CBZ-l-lysine-thiobenzyl; IPP,
isopentenyl pyrophosphate.T
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kine receptors CD62L and CCR7, CD45RA CD27  cells
had the CD45RO  memory phenotype, thus resembling
central memory    T cells (21). CD45RA CD27  cells
showed an effector phenotype; they had down-regulated
both CD62L and CCR7, but expressed high levels of re-
ceptors for inflammatory chemokines such as CCR2,
CCR5, CCR6, and CXCR3, and were CD45RO .
Altogether, these results identify three subsets of human
peripheral blood V 2 carrying distinct homing receptors:
one naive CD45RA CD27  and one memory CD45RA 
CD27  subset, preferentially expressing the lymph node
homing receptors CD62L and CCR7, and one effector
CD45RA CD27  subset preferentially expressing recep-
tors for inflammatory chemokines.
To confirm the migratory properties of the different
V 2 subsets, as deduced by chemokine receptor expres-
sion, we studied their distribution in lymph nodes and at
sites of inflammation. While in peripheral blood, cells
with the memory CD45RA CD27  phenotype represent
the most abundant V 2 subset; in lymph nodes, V 2 cells
with a naive phenotype (CD45RA CD27 ) are the pre-
dominant population (Fig. 2 A). About 25% of V 2 cells
within lymph nodes had a memory CD45RA CD27 
phenotype and only a small percentage expressed the
CD45RA CD27  phenotype. Similar to that finding
(Fig. 4 D; reference 1), the vast majority of V 2  cells in
the lymph nodes also coexpressed the V 9 chain (Fig. 2
A), and we also detected a small proportion of V 9  cells
that did not express V 2. The distribution of the three
V 2 T cell subsets in lymph nodes from six different do-
nors is shown in Fig. 2 B; whereas there was a certain
variability in subsets distribution, it was less pronounced
than that in PBMC. Further analysis of chemokine recep-
tor expression by lymph nodes V 2 T cells (Fig. 2 C)
shows that they express CCR7 and CD62L, but not
CCR5 and CXCR3.
Collectively, these data indicate that lymphoid organs
mainly contain V 2 cells with a naive or memory pheno-
type which express receptors for homing to secondary
lymphoid organs. Therefore, we assessed V 2 subset dis-
tribution in one ascite sample (Fig. 3 A) and in two
cerebrospinal fluids (Fig. 3, B and C), from three patients
affected by tuberculous peritonitis and tuberculous men-
ingitis, respectively. Fig. 3 shows that only two V 2 sub-
sets were detected at inflammatory sites: one effector
CD45RA CD27  subset and one abundant subset with
an unusual CD45RA CD27  phenotype, which resem-
bles a subset of terminally differentiated CD8 memory T
cells (22, 23). The relative percentages of these two sub-
Figure 1. Phenotypic characterization of
V 2 T cell subsets. (A) Peripheral blood mono-
nuclear cells were stained with antibodies to
V 2, CD45RA, and CD27. Upon analysis on
gated V 2  cells, three subsets were identified.
(B and C) Two-color FACS® analysis of pe-
ripheral blood mononuclear cells stained with
antibodies to V 2, CD3, and CD8. (D) Upon
analysis in a healthy population, the proportion
of cells within different subsets was variable
among individuals, the variability being more
pronounced in the CD45RA CD27  subset.
Table I. Chemokine Receptor, CD45RO and CD62L Expression 
on Subsets of V 2+ T Cells
CD45RA CD27  CD45RA CD27  CD45RA CD27 
CXCR3 6   2  (14) 20   3 (48) 95   11 (144)
CCR2 5   1 (18) 13   1 (21) 95   9 (38)
CCR5 8   2 (28) 25   2 (54) 80   12 (156)
CCR6 5   1 (12) 10   2 (14) 15   2 (27)
CCR7 75   10 (64) 63   7 (53) 0 (0)
CD62L 95   11 (73) 86   10 (66) 3   2 (4)
CD45RO 1   1 (5) 96   8 (125) 97   12 (164)
Three subsets of  peripheral blood V 2  cells were sorted  by expression
of CD45RA and CD27.  The sorted cells were stained and analyzed for
the expression of chemokine receptors, CD45RO and CD62L.  Values
indicate the percentage of positive cells   SD of three different
experiments. Values in brackets indicate the mean fluorescence intensity
(MFI) mean value.T
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394 Human V 2 T Cell Subsets
sets differed in the three tested inflammatory fluids, al-
though the CD45RA CD27  one was the only detect-
able V 9V 2 subset in the ascitic fluid (Fig. 3 A).
Additionally, V 2 T cells collected from these inflamma-
tory fluids expressed CCR5 and CXCR3 (Fig. 3, D–F),
but were virtually negative for CCR7 and CD62L ex-
pression.
Different subsets of human V 9V 2 T cells with distinct
homing receptors and localization routes might exert dif-
ferent immediate effector functions after short term anti-
genic stimulation (21). Therefore, we assessed proliferation,
cytokine production, and cytotoxic activities of naive
CD45RA CD27 , memory-type CD45RA CD27  and
CD45RA CD27  cells, and of the CD45RA CD27 
subset. Because this last subset was only detected in in-
flamed tissues, analysis was performed on V 9V 2 T cells
sorted from inflammatory fluids. To this end, sorted subsets
of V 9V 2 T cells were stimulated with IPP and prolifera-
Figure 2. Distribution of V 2 T cell subsets
in lymph nodes. (A) Mononuclear cells were
taken from inguinal lymph nodes of organ do-
nors. Cells were stained with antibodies to V 2,
CD45RA, and CD27. As a control, cells were
double stained with antibodies to V 2 and V 9.
(B) Analysis of the relative proportion of the
CD45RA CD27 , CD45RA CD27 , and
CD45RA CD27  subsets of V 2  T cells in
the lymph nodes of six donors. (C) V 2 T cell
subsets were sorted and analyzed for the expres-
sion of different chemokine receptors and
CD62L. Results similar to those shown here
were obtained in a total of six donors.
Figure 3. Distribution of V 2 T cell subsets at sites
of inflammation. Mononuclear cells were collected
from one ascitic (A) and two cerebrospinal fluids (B
and C) from three patients affected by tuberculous
peritonitis and meningitis, respectively. Cells were
stained with antibodies to V 2, CD45RA, and CD27.
(D–F) V 2 T cell subsets were sorted and analyzed for
the expression of different chemokine receptor and
CD62L.T
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tion; IFN  production and release of BLT-esterase (as a pa-
rameter of cytotoxicity) were tested.
As shown in Fig. 4, naive CD45RA CD27  cells were
only able to proliferate in response to IPP in vitro (Fig. 4
A), whereas they failed to produce IFN  (Fig. 4 B) and
release BLT-esterase (Fig. 4 C). Moreover, proliferative
response of naive CD45RA CD27  cells (Fig. 4 A) re-
quired stimulation with high IPP concentrations (gener-
ally 10 3–10 4 M). Memory-type CD45RA CD27  cells
showed a significant proliferative activity in response to
IPP in vitro, but peak proliferative response usually oc-
curred at IPP concentrations lower than those required
for proliferation of naive CD45RA CD27  cells (i.e.,
10 6–10 7 M). The different proliferative response of
naive CD45RA CD27  and memory-type CD45RA 
CD27  cells to different concentrations of IPP did not
seem to be due to an enrichment of IPP-nonreactive cells
in the former, as both subsets expressed the V 9 chain at a
similar extent (Fig. 4 D). Moreover, similar differential
sensitivity of naive CD45RA CD27  and memory-type
CD45RA CD27  cells was observed when plastic-bound
anti-CD3 monoclonal antibody was used as a stimulant in
the proliferation assay (unpublished data). Also, similarly
to CD45RA CD27  naive cells, CD45RA CD27  cells
produced very low amounts of IFN  (Fig. 4 B) and virtu-
ally failed to release BLT-esterase (Fig. 4 C). Conversely,
the memory-type CD45RA CD27  subset showed very
low capacity to proliferate upon in vitro stimulation by
IPP (Fig. 4 A), but secreted very high amounts of IFN 
(Fig. 4 B) and discrete amounts of BLT-esterase (Fig. 4
C). Finally, CD45RA CD27  cells taken from inflamma-
tory sites failed to proliferate (Fig. 4 A), produced low
amounts of IFN  (Fig. 4 B), but released substantial
amounts of BLT-esterase upon IPP stimulation in vitro
(Fig. 4 C). Additionally, these CD45RA CD27  cells
had prominent expression of intracellular perforin and
granulysin (unpublished data), supporting the notion that
they are differentiated to exert prevalent cytotoxic activi-
ties.
To determine the lineage differentiation pattern of these
four subsets of human V 2 T cells, we analyzed the dif-
ferentiation of purified CD45RA CD27 , CD45RA 
CD27 , and CD45RA CD27  subsets upon in vitro cul-
ture with IPP in the presence of IL-2 for 12 d, using a
long term culture system described previously to deter-
mine differentiation of CD4 T cells (21). As shown in Fig.
5 A, when CD45RA CD27  naive V 2 T cells were
stimulated with IPP, all cells lost CD45RA and became
CD45RO , but most of them ( 70%) retained CD27 ex-
pression. From a functional point of view, these cells had
strong proliferative capacity and low IFN  production
(Fig. 5 B). When memory-type CD45RA CD27  cells
were stimulated under the same conditions, almost all cells
recovered after a 12-d culture had lost CD27 expression
(Fig. 5 C), and upon subsequent restimulation in vitro
with IPP, produced high levels of IFN  (Fig. 5 D). Fi-
nally, CD45RA CD27  cells retained this phenotype af-
ter a 12-d culture (Fig. 5 E) and produced IFN  upon in
vitro stimulation with IPP (Fig. 5 F). Therefore, these data
suggest that, at least upon in vitro culture with antigen,
V 9V 2 T lymphocytes differentiate through the follow-
ing lineage pattern: CD45RA CD27   → CD45RA 
CD27   → CD45RA CD27   → CD45RA CD27 .
This possibility is in part supported by the analysis of
telomere length, which decreases as a consequence of
cell division (24), in different V 2 T cell subsets. Fig.
5 G shows that the length of telomeres progressively
decreases during the transition from CD45RA CD27 
to CD45RA CD27  to CD45RA CD27  phenotype,
with the latter subset having the lowest telomere length,
suggesting that it had undergone a high number of divi-
sions.
In this paper, we have defined discrete subsets of human
V 2 T cells based on expression patterns of CD45RA and
Figure 4. Different subsets of V 2 T cells display different effector functions. The four subsets
of V 2 T cells were sorted according to the expression of CD45RA and CD27 and were tested
for their ability to (A) proliferate, (B) produce IFN , and (C) release BLT-esterase (as a param-
eter of cytotoxic activity) upon in vitro stimulation with IPP. Comparable results were obtained
in eight different healthy donors. (A) Triangles, CD45RA CD27 ; diamonds, CD45RA 
CD27 ; squares, CD45RA CD27 ; and circles, CD45RA CD27 . (B and C) Black bars,
CD45RA CD27 ; hatched bars, CD45RA CD27 ; open bars, CD45RA CD27 ; and gray
bars, CD45RA CD27 . (D) The CD45RA CD27  and CD45RA CD27  subsets of V 2 
T cells were sorted and the expression of V 9 was assessed by FACS® staining.T
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396 Human V 2 T Cell Subsets
CD27; chemokine receptors and adhesion molecules; and
homing and functional properties. However, we must
point out that we have actually no formal evidence for the
last step of the proposed differentiation pathway to occur,
as we consistently failed to recover CD45RA CD27 
cells in IPP stimulated cultures of either CD45RA 
CD27  or CD45RA CD27  cells. Additionally, because
of the very low numbers and recovery of CD45RA 
CD27  V 2 T cells from inflammatory fluids, we could
not perform any further functional analysis on this sub-
set. Moreover, the frequency of these cells in the pe-
ripheral blood of healthy donors appears to be extremely
low ( 0.1%; unpublished data) and therefore not acces-
sible for assays that depend on discrete quantities of pu-
rified cells. Finally, the possibility should be considered
that transition from CD45RA CD27  to CD45RA 
CD27  cells may take place in peripheral compartments,
such as inflamed tissues, due to the presence of high
amounts of antigen or the local production of cytokines,
or both.
Based on works in different experimental mouse mod-
els, which have reported early accumulation of    cells at
sites of infection and inflammation (for review see refer-
ence 25),    T cells have been long considered as a readily
available pool of cells that migrate preferentially to sites of
inflammation and virtually lack long-term memory. How-
ever, analyses in humans have suggested that V 2 T cells
may provide memory-type secondary responses (13, 14),
and recent results in macaques have provided strong evi-
dence for both primary and recall V 2 T cell response to
Mycobacterium tuberculosis (15, 16), indicating that they con-
tribute to both innate and adaptive immune response
against microbial infection.
Data provided in this paper offer a plausible explanation
to this apparent paradox: the CD45RA CD27  memory
subset homing to the lymph node and lacking effector
functions may represent an antigen-primed V 2 popula-
tion trafficking to the lymph nodes and upon encounter
with antigen generates a new wave of effector cells. On
the other hand, CD45RA CD27  cells represent a readily
available pool of antigen-primed V 2 T cells which enter
the peripheral tissues, where they can eventually further
differentiate to CD45RA CD27  cells, and by their abil-
ity to produce cytokines and exert cytotoxicity can con-
tribute to the containment of invading microbial patho-
gens. Due to the protective role played by V 2 T cells in
immune responses against intracellular microbial patho-
gens, such as M. tuberculosis (15, 26), our results might be
of help in understanding the dynamics and expansion of
V 2 T cells in disease states such as tuberculosis and AIDS,
characterized by a dramatic loss of V 2 effector functions
(17, 27, 28).
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Figure 5. Lineage developmental pattern of different subsets of V 2 T cells. CD45RA CD27 ,
CD45RA CD27 , and CD45RA CD27  subsets of V 2 T cells were sorted from peripheral blood mononuclear
cells and cultured in vitro with IPP and IL-2 for 12 d. Cells were collected and tested for CD45RO and CD27 ex-
pression (A, C, and E) and for their ability to proliferate and produce IFN  upon restimulation with IPP in vitro
(B, D, and F). (G) The length of telomeres in CD45RA CD27  (lane 2), CD45RA CD27  (lane 3), and
CD45RA CD27  (lane 4) represents subsets of peripheral blood V 2 T cells. Lane 1, molecular weight markers.
kb, kilobases.T
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